Sanofi

Results: 1192



#Item
991EN  Case No COMP/M.3449 GLAXOSMITHKLINE / SANOFI-SYNTHELABO (ASSETS)

EN Case No COMP/M.3449 GLAXOSMITHKLINE / SANOFI-SYNTHELABO (ASSETS)

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2008-12-04 08:53:46
992PROGRAMA ESTÁGIO PÓS-DOUTORAL SANOFI 2013 EDITAL Nº [removed]Processo[removed][removed]

PROGRAMA ESTÁGIO PÓS-DOUTORAL SANOFI 2013 EDITAL Nº [removed]Processo[removed][removed]

Add to Reading List

Source URL: www.capes.gov.br

- Date: 2014-02-14 10:41:13
    993KENYA INDUSTRIAL PROPERTY INSTITUTE  INDUSTRIAL PROPERTY JOURNAL (Journal of Patents, Industrial Designs, Utility Models and Trade marks)  No[removed]

    KENYA INDUSTRIAL PROPERTY INSTITUTE INDUSTRIAL PROPERTY JOURNAL (Journal of Patents, Industrial Designs, Utility Models and Trade marks) No[removed]

    Add to Reading List

    Source URL: www.kipi.go.ke

    Language: English - Date: 2014-01-16 01:03:36
    994Q1 2014 RESULTS April 29, 2014 Forward Looking Statements  This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of

    Q1 2014 RESULTS April 29, 2014 Forward Looking Statements This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of

    Add to Reading List

    Source URL: en.sanofi.com

    Language: English - Date: 2014-06-20 12:38:41
    995PRESS RELEASE  Annual General Shareholder Meeting of May 5, 2014   

    PRESS RELEASE Annual General Shareholder Meeting of May 5, 2014   

    Add to Reading List

    Source URL: en.sanofi.com

    Language: English - Date: 2014-05-07 11:04:13
    996PRESS KIT  February 2014 FIGHTING AGAINST MATERNAL AND NEONATAL MORTALITY

    PRESS KIT February 2014 FIGHTING AGAINST MATERNAL AND NEONATAL MORTALITY

    Add to Reading List

    Source URL: en.sanofi.com

    Language: English - Date: 2014-06-24 04:44:12
    997PRESS RELEASE  FDA Accepts Sanofi’s New Drug Application for Basal Insulin Toujeo® – Toujeo dossier already accepted by EMA – Paris, France – July 8, 2014 – Sanofi (EURONEXT: SAN and NYSE: SNY) announced today

    PRESS RELEASE FDA Accepts Sanofi’s New Drug Application for Basal Insulin Toujeo® – Toujeo dossier already accepted by EMA – Paris, France – July 8, 2014 – Sanofi (EURONEXT: SAN and NYSE: SNY) announced today

    Add to Reading List

    Source URL: en.sanofi.com

    Language: English - Date: 2014-07-08 00:57:36
    998R&D Pipeline Summary Table(1) Phase I Phase II  Phase III

    R&D Pipeline Summary Table(1) Phase I Phase II Phase III

    Add to Reading List

    Source URL: en.sanofi.com

    - Date: 2014-07-22 08:14:57
      999EUROPEANS AND COUNTERFEIT MEDICINES OPINION SURVEY HAPPYCURIOUS FOR SANOFI  When it comes to counterfeit drugs,

      EUROPEANS AND COUNTERFEIT MEDICINES OPINION SURVEY HAPPYCURIOUS FOR SANOFI When it comes to counterfeit drugs,

      Add to Reading List

      Source URL: en.sanofi.com

      Language: English - Date: 2014-06-16 11:21:43
      1000[removed]to that. My own comments were meant to be a

      [removed]to that. My own comments were meant to be a

      Add to Reading List

      Source URL: www.fda.gov

      Language: English - Date: 2009-01-05 15:12:35